706 research outputs found
Failed Switching off in the MIBI-Parathyroid Scintigraphy in a Dialyzed Patient with Secondary Hyperparathyroidism Responsive to Cinacalcet Therapy
The aims of your case report is to show the predictivity of 99mTc-sestamibi (MIBI) scintigraphy and doppler ultrasound imaging on secondary hyperparathyroidism (SHPT) in a patient responsive to calcimimetic treatment. Moreover, it has been reported that calcimimetic has great potential in reducing the volume of the parathyroid gland. On the other hand, the MIBI scintigraphy is considered a crucial diagnostic procedure to monitor the response to therapy in terms of turnover and cellular metabolism; whereas, ultrasound to monitor the volume variation in response to treatment. It is described the case of a 73-year-old man on hemodialysis from 1995 for ESRD. Within 2 years the patient gradually developed SHPT with progressively increased iPTH up to 1,000âÏg/ml. The ultrasound, highlighted the presence of two parathyroid hyperplasia, confirmed by scintigraphy, showing focal increase uptake of sestamibi in the same anatomical areas. As a result of the patient's refusal to perform a parathyroidectomy, cinacalcet, was administered (65âmg overage daily dose). After a year of treatment, there was a striking decrease of iPTH (from 1300 to 57âÏg/ml, â95%); but, on the contrary to expectations, this positive metabolic outcome, was not followed by parathyroid changes in ultrasound and scintigraphic findings
Spread of ductal carcinoma in situ into a phyllodes breast tumour: a case report
Phyllodes are uncommon fibroepithelial breast tumours. Here, we present the case of a 42-year-old woman who presented to our breast centre with a palpable breast mass, which was initially suspected and treated as fibroadenoma but was finally revealed to be a phyllodes tumour. Histopathological examination identified ductal carcinoma in situ (DCIS) within the entire volume of the fibroepithelial tumour. The literature on these transformations is still limited, and the treatment is not standardised
Medical and surgical interventions to improve the quality of life for endometriosis patients: a systematic review
Endometriosis impairs the quality of life (QoL) of many women, including their social relationships, daily activity,
productivity at work, and family planning. The aim of this review was to determine the instruments used to
examine QoL in previous clinical studies of endometriosis and to evaluate the effect of medical and surgical
interventions for endometriosis on QoL. We conducted a systematic search and review of studies published
between January 2010 and December 2020 using MEDLINE. Search terms included âendometriosisâ and âquality of
life.â We only selected studies that used a standardized questionnaire to evaluate QoL before and after medical or
surgical interventions. Only articles in the English language were examined. The initial search identified 720 results.
After excluding duplicates and applying inclusion criteria, 37 studies were selected for analysis. We found that the
two scales most frequently used to measure QoL were the Short Form-36 health survey questionnaire (SF-36) and
the Endometriosis Health Profile-30 (EHP-30). Many medical and surgical treatments demonstrated comparable
benefits in pain control and QoL improvement. There is no clear answer as to what is the best treatment for
improving QoL because each therapy must be personalized for the patient and depends on the womanâs goals. In
conclusion, women must be informed about endometriosis and given easily accessible information to improve
treatment adherence and their QoL
A Methodological Approach For The Effective Infiltration Assessment In A Coastal Groundwater
Accurate estimates of spatial and temporal distribution of groundwater recharge are of utmost importance to protect groundwater systems. In coastal areas, the fragility of the systems makes such estimates critical for the correct management and protection of water resources from saltwater intrusion.
The Muravera coastal plain, in the south-eastern Sardinia, has been studied since 1960, due to important saltwater intrusion phenomena. Since the early fifties, the natural hydrodynamic equilibrium between groundwater, surface-water and seawater has been deeply modified by the construction of four dams across the Flumendosa river and the development of agriculture, tourism and aquaculture activities along the coast. To implement an integrated and sustainable management system addressed to slow down the process of saltwater intrusion and, on the other, satisfy human requirements, it is important to develop a flexible scenario analysis system that considers changes of land-use and inputs to the hydrogeological system, also in relation to climate change.
In this study, the innovative Soil Water Balance code (SWB) has been applied to the Muravera plain groundwater body to calculate spatial and temporal variations of groundwater recharge. The code calculates the recharge (R) by using geographic system (GIS) data layers in combination with tabular climatological data. It is based on a modified Thornthwaite - Mather soil water balance approach, with components of the soil water balance calculated at a daily time-step.
A combined experimental approach of hydrogeological, satellite remote sensing and pedological methodologies has been applied to derive data layers describing local features of: (1) land-use classification, (2) hydrologic soil group, (3) flow direction, and (4) soil-water capacity.
The code has proved to be promising for the effective infiltration assessment and it can be easily updated with high resolution data acquired in the field and from satellite images
Identification of signal peptide features for substrate specificity in human Sec62/Sec63-dependent ER protein import
In mammalian cells, oneâthird of all polypeptides are integrated into the membrane or translocated into the lumen of the endoplasmic reticulum (ER) via the Sec61 channel. While the Sec61 complex facilitates ER import of most precursor polypeptides, the Sec61âassociated Sec62/Sec63 complex supports ER import in a substrateâspecific manner. So far, mainly posttranslationally imported precursors and the two cotranslationally imported precursors of ERj3 and prion protein were found to depend on the Sec62/Sec63 complex in vitro. Therefore, we determined the rules for engagement of Sec62/Sec63 in ER import in intact human cells using a recently established unbiased proteomics approach. In addition to confirming ERj3, we identified 22 novel Sec62/Sec63 substrates under these in vivoâlike conditions. As a common feature, those previously unknown substrates share signal peptides (SP) with comparatively longer but less hydrophobic hydrophobic region of SP and lower carboxyâterminal region of SP (Câregion) polarity. Further analyses with four substrates, and ERj3 in particular, revealed the combination of a slowly gating SP and a downstream translocationâdisruptive positively charged cluster of amino acid residues as decisive for the Sec62/Sec63 requirement. In the case of ERj3, these features were found to be responsible for an additional immunoglobulin heavyâchain binding protein (BiP) requirement and to correlate with sensitivity toward the Sec61âchannel inhibitor CAM741. Thus, the human Sec62/Sec63 complex may support Sec61âchannel opening for precursor polypeptides with slowly gating SPs by direct interaction with the cytosolic aminoâterminal peptide of Sec61α or via recruitment of BiP and its interaction with the ERâlumenal loop 7 of Sec61α. These novel insights into the mechanism of human ER protein import contribute to our understanding of the etiology of SEC63âlinked polycystic liver disease
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder
Although delivery of a wild-type copy of the mutated gene to cells represents the most effective approach for a monogenic disease, proof-of-concept studies highlight significant efficacy caveats for treatment of brain disorders. Herein, we develop a cross-correction-based strategy to enhance the efficiency of a gene therapy for CDKL5 deficiency disorder, a severe neurodevelopmental disorder caused by CDKL5 gene mutations. We created a gene therapy vector that produces an Igk-TATk-CDKL5 fusion protein that can be secreted via constitutive secretory pathways and, due to the cell-penetration property of the TATk peptide, internalized by cells. We found that, although AAVPHP.B_Igk-TATk-CDKL5 and AAVPHP.B_CDKL5 vectors had similar brain infection efficiency, the AAVPHP.B_Igk-TATk-CDKL5 vector led to higher CDKL5 protein replacement due to secretion and penetration of the TATk-CDKL5 protein into the neighboring cells. Importantly, Cdkl5 KO mice treated with the AAVPHP.B_Igk-TATk-CDKL5 vector showed a behavioral and neuroanatomical improvement in comparison with vehicle or AAVPHP.B_CDKL5 vector-treated Cdkl5 KO mice. In conclusion, we provide the first evidence that a gene therapy based on a cross-correction approach is more effective at compensating Cdkl5-null brain defects than gene therapy based on the expression of the native CDKL5, opening avenues for the development of this innovative approach for other monogenic diseases
Intrinsic time resolution of 3D-trench silicon pixels for charged particle detection
In the last years, high-resolution time tagging has emerged as the tool to
tackle the problem of high-track density in the detectors of the next
generation of experiments at particle colliders. Time resolutions below 50ps
and event average repetition rates of tens of MHz on sensor pixels having a
pitch of 50m are typical minimum requirements. This poses an important
scientific and technological challenge on the development of particle sensors
and processing electronics. The TIMESPOT initiative (which stands for TIME and
SPace real-time Operating Tracker) aims at the development of a full prototype
detection system suitable for the particle trackers of the next-to-come
particle physics experiments. This paper describes the results obtained on the
first batch of TIMESPOT silicon sensors, based on a novel 3D MEMS (micro
electro-mechanical systems) design. Following this approach, the performance of
other ongoing silicon sensor developments has been matched and overcome, while
using a technology which is known to be robust against radiation degradation. A
time resolution of the order of 20ps has been measured at room temperature
suggesting also possible improvements after further optimisations of the
front-end electronics processing stage.Comment: This version was accepted to be published on JINST on 21/07/202
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib
Patients with chronic myeloid leukemia (CML) treated with nilotinib or ponatinib may experience arterial occlusive events (AOEs). It is currently recommended to thoroughly assess cardiovascular risk factors before treating CML. We identified 455 consecutive CML adult patients, 335 treated with nilotinib and 120 with ponatinib; 380 patients without previous cardiovascular diseases or diabetes were stratified according to the Systematic Coronary Risk Evaluation (SCORE2) and SCORE2-Older Persons (SCORE2-OP). This updated algorithm from the European Society of Cardiology (ESC) estimates a 10-year risk of fatal and non-fatal cardiovascular diseases. It is based on sex, age, smoking habits, systolic blood pressure, non-high-density lipoprotein cholesterol, and European geographical region of cardiovascular risk. The SCORE2/SCORE2-OP algorithm translated more patients (50.2%) to the high-very high cardiovascular risk category than the previous SCORE (25.3%). Patients with a high to very high SCORE2/SCORE2-OP risk showed a significantly higher incidence rate of AOEs (69.2% vs. 46.5%, pâ<â0.001). The older SCORE was less specific in estimating AOEs in patients classified as low-intermediate risk (69.8 vs. 54.2%). In multivariate analysis, no associations were found between AOEs and gender, age, and type or dose of tyrosine kinase inhibitor. Only the SCORE2/SCORE2-OP risk was confirmed as a significant predictive factor (pâ=â0.028; hazard ratioâ=â2.2; 95% confidence intervalâ=â1.1-4.5). Patients with AOEs required, in most cases, imaging diagnostic tests, additional drugs, and sometimes invasive procedures, increasing access to visits and hospital management. This real-life study suggested that the SCORE2 and SCORE2-OP charts could help identify cardiovascular fragility in CML patients providing them with more attention and a proper TKI selection
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection
Background: The diversity in the clinical course of COVID-19 has been related to differences in innate and adaptative immune response mechanisms. Natural killer (NK) lymphocytes are critical protagonists of human host defense against viral infections. It would seem that reduced circulating levels of these cells have an impact on COVID-19 progression and severity. Their activity is strongly regulated by killer-cell immuno-globulin-like receptors (KIRs) expressed on the NK cell surface. The present study's focus was to investigate the impact of KIRs and their HLA Class I ligands on SARS-CoV-2 infection.
Methods: KIR gene frequencies, KIR haplotypes, KIR ligands and combinations of KIRs and their HLA Class I ligands were investigated in 396 Sardinian patients with SARS-CoV-2 infection. Comparisons were made between 2 groups of patients divided according to disease severity: 240 patients were symptomatic or paucisymptomatic (Group A), 156 hospitalized patients had severe disease (Group S). The immunogenetic characteristics of patients were also compared to a population group of 400 individuals from the same geographical areas.
Results: Substantial differences were obtained for KIR genes, KIR haplotypes and KIR-HLA ligand combinations when comparing patients of Group S to those of Group A. Patients in Group S had a statistically significant higher frequency of the KIR A/A haplotype compared to patients in Group A [34.6% vs 23.8%, OR = 1.7 (95% CI 1.1-2.6); P = 0.02, Pc = 0.04]. Moreover, the KIR2DS2/HLA C1 combination was poorly represented in the group of patients with severe symptoms compared to those of the asymptomatic-paucisymptomatic group [33.3% vs 50.0%, OR = 0.5 (95% CI 0.3-0.8), P = 0.001, Pc = 0.002]. Multivariate analysis confirmed that, regardless of the sex and age of the patients, the latter genetic variable correlated with a less severe disease course [ORM = 0.4 (95% CI 0.3-0.7), PM = 0.0005, PMC = 0.005].
Conclusions: The KIR2DS2/HLA C1 functional unit resulted to have a strong protective effect against the adverse outcomes of COVID-19. Combined to other well known factors such as advanced age, male sex and concomitant autoimmune diseases, this marker could prove to be highly informative of the disease course and thus enable the timely intervention needed to reduce the mortality associated with the severe forms of SARS-CoV-2 infection. However, larger studies in other populations as well as experimental functional studies will be needed to confirm our findings and further pursue the effect of KIR receptors on NK cell immune-mediated response to SARS-Cov-2 infection
Outcomes of pregnancies after kidney transplantation: lessons learned from CKD. A comparison of transplanted, nontransplanted chronic kidney disease patients and low-risk pregnancies: a multicenter nationwide analysis.
BACKGROUND: Kidney transplantation (KT) may restore fertility in CKD. The reasons why materno-foetal outcomes are still inferior to the overall population are only partially known. Comparison with the CKD population may offer some useful insights for management and counselling.Aim of this study was to analyse the outcomes of pregnancy after KT, compared with a large population of non-transplanted CKD patients and with low-risk control pregnancies, observed in Italy the new millennium.
METHODS: We selected 121 live-born singletons after KT (Italian study group of kidney in pregnancy, national coverage about 75%), 610 live-born singletons in CKD and 1418 low-risk controls recruited in 2 large Italian Units, in the same period (2000-2014). The following outcomes were considered: maternal and foetal death; malformations; preterm delivery; small for gestational age baby (SGA); need for the neonatal intensive care unit (NICU); doubling of serum creatinine or increase in CKD stage. Data were analysed according to kidney diseases, renal function (staging according to CKD-EPI), hypertension, maternal age, partity, ethnicity.
RESULTS: Materno-foetal outcomes are less favourable in CKD and KT as compared with the low-risk population. CKD stage and hypertension are important determinants of results. KT patients with e-GFR >90 have worse outcomes compared with CKD stage 1 patients; the differences level off when only CKD patients affected by glomerulonephritis or systemic diseases ('progressive CKD') are compared with KT. In the multivariate analysis, risk for preterm and early-preterm delivery was linked to CKD stage (2-5 versus 1: RR 3.42 and 3.78) and hypertension (RR 3.68 and 3.16) while no difference was associated with being a KT or a CKD patient.
CONCLUSIONS: The materno-foetal outcomes in patients with kidney transplantation are comparable with those of nontransplanted CKD patients with similar levels of kidney function impairment and progressive and/or immunologic kidney diseas
- âŠ